Press Releases

Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.

• Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address considerable unmet needs
• Combined pipeline extends from pre-clinical to registration studies, with near-term clinical and regulatory milestones
• Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end